SILEXION THERAPEUTICS CORP Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value
SILEXION THERAPEUTICS CORP (SLXN) had Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value of $0 as of 2024-12-31, per its 8-K filed 2025-08-20.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue · last filed 2025-08-20
- 2024-12-31: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $0.00.
- 2024-09-30: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $0.00.
- 2024-06-30: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $15.06M.
- 2023-12-31: Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value $15.06M.
| Period end | Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value |
|---|---|
| 2024-12-31 | $0.00 8-K · filed 2025-08-20 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $15.06M 10-Q · filed 2024-08-29 |
| 2023-12-31 | $15.06M 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |